HHS Secretary Robert F. Kennedy, Jr. has issued a 90-day halt on a $460 million COVID-19 vaccine contract with Vaxart Inc. This decision represents a significant shift from the previous administration's approach to public health and vaccine policy.
• The stop-work order affects a contract intended for large-scale clinical trials involving 10,000 participants.
• This decision is a move away from the Biden administration’s heavy pandemic spending and mandates and aims for more transparency and fiscal responsibility under the Trump administration.
• The Vaxart contract was part of the larger $4. 7 billion Project Next Gen initiative, with Vaxart receiving $240 million for preliminary studies and another $230 million pending for large-scale trials.
• Secretary Kennedy's pause aligns with efforts to evaluate past pandemic spending and the overall health policy agenda, including the Make America Healthy Again Commission, which will focus on chronic health issues like childhood autism.
• Kennedy's leadership emphasizes the need for scientifically rigorous vaccine development while addressing concerns about government overreach and the need for accountability.
• Despite the temporary halt, Vaxart can still receive funding for medical monitoring of participants from prior trials, and the contract may be reinstated based on future evaluations.
• This action is perceived as a response to criticisms of the Biden administration's pandemic policies and reflects a broader change in federal public health strategy.
Kennedy’s decision to pause the Vaxart contract symbolizes a commitment to responsible and accountable public health practices. It reflects a desire to focus on both fiscal prudence and the scientific integrity of vaccine development, aiming to better address America’s health challenges.
https://www.naturalnews.com/2025-03-01-rfk-jr-halts-biden-era-covid-vaccine-contract.html
No comments:
Post a Comment